Federal judge blocks FTC probes into trans medicine groups, citing 'extensive evidence of animus'https://www.advocate.com/wpath-endocrine-society-legal-victory 🔗Christopher Wiggins (8 May 2026)
President Donald Trump suffered a pair of legal setbacks Thursday after a federal judge in Washington, D.C., blocked the Federal Trade Commission from enforcing investigative demands against two of the nation's most influential medical organizations involved in transgender health care guidance.
Chief Judge James Boasberg of the U.S. District Court for the District of Columbia granted preliminary injunctions to both the World Professional Association for Transgender Health and the Endocrine Society, temporarily halting FTC investigations that the groups argued were politically motivated and unconstitutional.
In separate lawsuits filed in D.C., WPATH and the Endocrine Society accused the administration of weaponizing federal investigative powers to intimidate organizations that support evidence-based medical care for transgender patients.
Boasberg appeared deeply skeptical of the administration's motives in both rulings, repeatedly pointing to what he described as evidence of hostility toward the organizations and their views on clinical standards for gender dysphoria treatment.
The judge explicitly tied that conclusion to the administration's broader conduct surrounding transgender health care. "This Court's Opinion in the parallel suit brought by the Endocrine Society details the range and depth of animus displayed by the President and agency leadership toward gender-affirming care," Boasberg wrote.
